BioNTech IMFS is a Contract Development and Manufacturing Organisation specialised in the industrialisation of cell and gene therapy products such as viral vectors, cellular products and in vitro transcribed mRNA, located in Germany.
Based on extensive expertise in molecular biology, virology and cell biology as well as an understanding of the regulatory prerequisites, our GMP experts support you to develop and manufacture your products in a safe and cost-efficient way. We offer a complete service spectrum from process development through clinical trial medication to in-market supply in our state-of-the-art facility. BioNTech IMFS so far has produced >1000 products for cellular therapies supporting numerous clinical trials for gene therapy worldwide.
This year marks BioNTech IMFS’ 20th anniversary!